Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer

被引：0
|
作者：
Tu, Hengjia [1 ]
Zhang, Yuzhuo [1 ]
You, Zhixuan [1 ]
机构：
[1] Chinese Acad Med Sci, Natl Canc Ctr, Beijing, Peoples R China
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024年 / 332卷 / 04期
关键词：
D O I：
10.1001/jama.2024.10480
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Immunotyping of tumor-infiltrating lymphocytes in triple-negative breast cancer and genetic characterization
    Sofia Gomez-Macias, Gabriela
    Molinar-Flores, Guillermo
    Lopez-Garcia, Carlos A.
    Santuario-Facio, Sandra
    Decanini-Arcaute, Horacio
    Valero-Elizondo, Javier
    Trevino-Alvarado, Victor
    Ortiz-Lopez, Rocio
    Dono, Antonio
    Esteban-Zubero, Eduardo
    Alatorre-Jimenez, Moises A.
    Villarreal Garza, Cynthia
    Pena-Curiel, Omar
    Cardona-Huerta, Servando
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [22] Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
    Floris, Giuseppe
    Richard, Francois
    Hamy, Anne-Sophie
    Jongen, Lynn
    Wildiers, Hans
    Ardui, Jan
    Punie, Kevin
    Smeets, Ann
    Berteloot, Patrick
    Vergote, Ignace
    De Croze, Diane
    Meseure, Didier
    Salomon, Anne
    Lae, Marick
    Reyal, Fabien
    Biganzoli, Elia
    Neven, Patrick
    Desmedt, Christine
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (02): : 146 - 153
  • [23] Tumor-infiltrating lymphocytes independently predict the prognosis of triple-negative breast cancer
    Krome, Susanne
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (12) : 672 - 672
  • [24] Tumor-infiltrating Lymphocytes independently predict the Prognosis of triple-negative Breast Cancer
    Krome, Susanne
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (07)
  • [25] Prognostic value of routinely determined tumor infiltrating lymphocytes in triple-negative breast cancer.
    Golicnik, Jana Pahole
    Gazic, Barbara
    Ovcaricek, Tanja
    Matos, Erika
    Borstnar, Simona
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Characterization of tumor-infiltrating lymphocytes and their spatial distribution in triple-negative breast cancer
    Han, Eunkyung
    Choi, Hye Yeon
    Kwon, Hyun Jung
    Chung, Yul Ri
    Shin, Hee-Chul
    Kim, Eun-Kyu
    Suh, Koung Jin
    Kim, Se Hyun
    Kim, Jee Hyun
    Park, So Yeon
    BREAST CANCER RESEARCH, 2024, 26 (01)
  • [27] Effect of Lipid Levels on Tumor-Infiltrating Lymphocytes and Prognosis in Patients with Triple-Negative Breast Cancer
    AiErken, NiJiati
    Shao, Nan
    Liu, Yuhong
    Shi, Huijuan
    Shi, Yawei
    Yuan, Zhongyu
    Lin, Ying
    BREAST CARE, 2023, 18 (05) : 390 - 398
  • [28] Correlation Between MRI and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer
    Ku, You Jin
    Kim, Hak Hee
    Cha, Joo Hee
    Shin, Hee Jung
    Baek, Soo Heui
    Lee, Hee Jin
    Gong, Gyungyub
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2016, 207 (05) : 1146 - 1151
  • [29] Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy
    Geurts, Veerle C. M.
    Balduzzi, Sara
    Steenbruggen, Tessa G.
    Linn, Sabine C.
    Siesling, Sabine
    Badve, Sunil S.
    DeMichele, Angela
    Ignatiadis, Michail
    Leon-Ferre, Roberto A.
    Goetz, Matthew P.
    Wolff, Antonio C.
    Klar, Natalie
    Michiels, Stefan
    Loi, Sherene
    Adams, Sylvia
    Horlings, Hugo M.
    Sonke, Gabe S.
    Salgado, Roberto
    Kok, Marleen
    JAMA ONCOLOGY, 2024,
  • [30] Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
    Makiko Ono
    Hitoshi Tsuda
    Chikako Shimizu
    Sohei Yamamoto
    Tatsuhiro Shibata
    Harukaze Yamamoto
    Taizo Hirata
    Kan Yonemori
    Masashi Ando
    Kenji Tamura
    Noriyuki Katsumata
    Takayuki Kinoshita
    Yuichi Takiguchi
    Hideki Tanzawa
    Yasuhiro Fujiwara
    Breast Cancer Research and Treatment, 2012, 132 : 793 - 805
12345